Back to News
Market Impact: 0.6

Forget Intel: This AI Chip Kingpin Is the Real Way to Ride the Generative AI Gold Rush

TSMAAPLAMDMRVLAVGONFLXNDAQ
Artificial IntelligenceTechnology & InnovationTrade Policy & Supply ChainCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsAntitrust & CompetitionInvestor Sentiment & Positioning
Forget Intel: This AI Chip Kingpin Is the Real Way to Ride the Generative AI Gold Rush

Intel reported Q4 FY2025 revenue down 4% year‑over‑year to $13.7 billion with non‑GAAP EPS up 15% to $0.15, but guided to break‑even adjusted EPS in Q1 (versus Street $0.06) and stagnant revenue, attributing weakness to acute supply shortages that it expects to ease starting Q2 2026; the guidance triggered a ~12% aftermarket share drop. The piece contrasts this with Nvidia’s dominance in AI chips (estimated 86% share at end‑2025), TSMC allocating ~70% of advanced packaging capacity to Nvidia, and Bloomberg forecasts of a $604 billion AI‑accelerator market by 2033 with Nvidia capturing 70–75%, arguing Nvidia’s growth prospects and lower ~24x forward multiple make it a more attractive investment versus Intel’s ~85x forward valuation.

Analysis

Market structure: Nvidia (NVDA) and TSMC (TSM) are the clear winners — Nvidia’s ~86% AI-GPU share and TSMC’s ~70% allocation of advanced packaging in 2025 give them multi-year pricing power in AI accelerators (Bloomberg $604B AI-accelerator TAM to 2033; GPUs ~80%). Intel (INTC) is the near-term loser: supply-constrained DCAI revenue and guidance for Q1 weakness will compress upside vs. NVDA’s 24x forward vs. INTC’s ~85x forward multiples, creating a high-risk valuation gap. AVGO/MRVL are secondary beneficiaries in custom AI silicon and networking capex. Risk assessment: Tail risks include antitrust/export controls on NVDA, a sudden TSMC-capacity shift away from NVDA (>10 percentage points), a hyperscaler demand pullback >10% YoY, or Taiwan geopolitics disrupting supply — any of these could cut NVDA upside materially in 3–18 months. Hidden dependencies: NVDA’s growth relies on TSMC packaging and hyperscaler adoption + CUDA software lock-in; Intel’s recovery depends on wafer capacity ramping in Q2–H2 2026. Key catalysts: TSMC capacity guidance (next 60–120 days), NVDA earnings & FY guidance, Intel supply updates and customer wins (AWS/Meta) in Q2 2026. Trade implications: Tactical longs: overweight NVDA into the next 6–12 months (use 9–12m call spreads to reduce cash outlay). Tactical shorts/hedges: short/put INTC sized to 0.5–1.5% of portfolio given execution risk through Q1–Q2 2026. Pair trade: long NVDA, short INTC (delta-neutral sizing) to capture spread if NVDA maintains share. Opportunistic longs: MRVL/AVGO (0.5–1% each) as plays on custom chips/networks with lower multiples; TSM long for semiconductor supply exposure with stop-loss if TSMC cuts capex guidance. Contrarian angles: Consensus underestimates concentration risk — NVDA’s dependence on TSMC packaging and hyperscalers is a single-point-of-failure; the market may be underpricing a 20–30% downside scenario if either TSMC allocation falls or NVDA misses guidance by >5%. Conversely, INTC’s sell-off could be overdone if supply materially improves in Q2 2026: consider a small, disciplined rebound trade (buy INTC after confirmed volume ramp or guidance upgrade). Historical parallel: foundry/packaging re-allocations have swung leader pricing power quickly in past cycles, so monitor 1–3 month capacity signals closely.